CHCWM – Cancer & Hematology Centers of West Michigan

In the News

As the largest physician-owned oncology and hematology practice in Michigan, we are often in the news. See what we've been up to.
FDA approves START Midwest-tested therapy for lung and thyroid cancers

The U.S. Food and Drug Association (FDA) recently approved Retevmo® (selpercatinib) capsules. START Midwest, led by Nehal Lakhani, MD, PhD, researched the effectiveness of this therapy in thyroid and lung cancer patients whose tumors have a mutation or fusion in Read more »


CHC’s Drive-Up Blood Draw Station featured on WOOD TV8

CHC’s Director of Laboratory Services Eve Graham was featured on WOOD TV8 this morning to discuss our Drive-Up Blood Draw Station. To see the full interview, click the link below: Watch the Video Read more »


CHC’s Dr. Amy Vander Woude talks patient care amidst COVID-19 on FOX 17

Cancer and Hematology Centers of Western Michigan (CHC)’s Amy Vander Woude, MD, spoke with FOX 17 Morning News this morning about CHC’s dedication to quality patient care during COVID-19. To see the interview, click the link below. Watch the Video Read more »


CHCWM named one of Nation’s Best and Brightest Companies to Work For® for second year in a row

Cancer and Hematology Centers of Western Michigan (CHCWM) has been named one of the Nation’s Best and Brightest Companies to Work For® for the second year in a row. CHCWM was one of 540 winning companies selected out of 5,000 Read more »


CHCWM clinical trial published in esteemed lung cancer journal

Cancer & Hematology Centers of Western Michigan (CHCWM)’s ongoing ADRIATIC clinical trial study design and eligibility was recently published in leading academic journal, Clinical Lung Cancer. ADRIATIC is the first international phase III trial studying the benefit of immunotherapy as consolidation Read more »


CHCWM oncologist Sreenivasa Chandana, M.D., Ph.D., publishes article in ‘Journal of Gastrointestinal Oncology’

Cancer and Hematology Centers of Western Michigan (CHCWM) oncologist Sreenivasa Chandana, M.D., Ph.D., is one of six authors of “Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database,” which was published in Journal of Gastrointestinal Read more »


Page 6 of 9
Page: